Japara (ASX:JHC) share price soars 18% on takeover news

Japara's board is recommending shareholders vote in favour of a takeover offer.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Japara Healthcare Ltd (ASX: JHC) share price is gaining this morning after the company released the latest news of its takeover offer.

The offer would see the residential aged care operator acquired by Little Company of Mary Health Care Ltd (Calvary).

Right now, the Japara share price is 18.45% higher than its previous close. Shares in the company are currently swapping hands for $1.38 apiece.

Let's take a closer look at today's news from Japara.

golden hawk flying high in the sky

Image source: Getty Images

Japara recommends accepting takeover offer

The Japara share price is shooting higher after it announced it's entered a scheme of implementation deed for Calvary to purchase all Japara's shares.

The Japara board has unanimously recommended shareholders vote in favour of the scheme.

The offer would see each Japara shareholder receiving $1.40 of cash per share. That represents a 75% premium on the Japara share price's close on 29 April 2021.

The market first heard news of the acquisition on 30 April, leading the Japara share price to gain 26%.

The offer also represents an 81% premium on the 30-day volume weighted average price prior to 30 April.

Calvary is a Catholic not-for-profit organisation. It operates 14 hospitals, 17 retirement and aged care facilities, and a network of community care centres.

The scheme is conditional upon factors including Japara not receiving a better offer, an independent expert concluding the scheme is in shareholders' best interests, and shareholder approval.

Japara shareholders will have the chance to vote on the scheme in October 2021.

Japara Healthcare share price snapshot

2021 has been a good year so far for Japara's shares.

Right now, they're trading for 121% more than they were at the start of the year. They are also swapping hands for 175% more than they were this time last year.

The company has a market capitalisation of around $311 million, with approximately 266 million shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Orthocell caps 26% surge this week with first US Military Surgery

The company's commercial rollout is off to a good start.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX health tech stock just hit a new record high. Could it go even higher?

Morgans believes there's still upside to be had.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Down almost 20% this year, how high could Mesoblast shares go?

The forward pipeline is looking promising.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?

These three stocks might be too cheap to ignore.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

How much would $10,000 become if CSL shares returned to their record high?

After a sharp decline, CSL is in a new phase. The question is what happens next.

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
Healthcare Shares

Why this ASX biotech stock just rocketed 89% today

Immutep shares rocket after a fresh FDA win

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Orthocell shares soar 22% on landmark US breakthrough

The company has been given approval to sell Remplir in more than 220 hospitals in the US.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX biotech stock just jumped again as its lead drug trial moves ahead

The latest trial milestone sends this ASX biotech stock higher today.

Read more »